title: Adaptive evolution of Escherichia coli to an α-peptide/β-peptoid peptidomimetic induces stable resistance.
abstract: Antimicrobial peptides (AMPs) and synthetic analogues thereof target conserved structures of bacterial cell envelopes and hence, development of resistance has been considered an unlikely event. However, recently bacterial resistance to AMPs has been observed, and the aim of the present study was to determine whether bacterial resistance may also evolve against synthetic AMP analogues, e.g. α-peptide/β-peptoid peptidomimetics. E. coli ATCC 25922 was exposed to increasing concentrations of a peptidomimetic (10 lineages), polymyxin B (10 lineages), or MilliQ water (4 lineages) in a re-inoculation culturing setup covering approx. 500 generations. All 10 lineages exposed to the peptidomimetic adapted to 32 × MIC while this occurred for 8 out of 10 of the polymyxin B-exposed lineages. All lineages exposed to 32 × MIC of either the peptidomimetic or polymyxin B had a significantly increased MIC (16-32 ×) to the selection agent. Five transfers (≈ 35 generations) in unsupplemented media did not abolish resistance indicating that resistance was heritable. Single isolates from peptidomimetic-exposed lineage populations displayed MICs against the peptidomimetic from wild-type MIC to 32 × MIC revealing heterogeneous populations. Resistant isolates showed no cross-resistance against a panel of membrane-active AMPs. These isolates were highly susceptible to blood plasma antibacterial activity and were killed when plasma concentrations exceeded ≈ 30%. Notably, MIC of the peptidomimetic against resistant isolates returned to wild-type level upon addition of 25% plasma. Whole-genome sequencing of twenty isolates from four resistant lineages revealed mutations, in murein transglycosylase D (mltD) and outer-membrane proteins, which were conserved within and between lineages. However, no common resistance-conferring mutation was identified. We hypothesise that alterations in cell envelope structure result in peptidomimetic resistance, and that this may occur via several distinct mechanisms. Interestingly, this type of resistance result in a concomitant high susceptibility towards plasma, and therefore the present study does not infer additional concern for peptidomimetics as future therapeutics.
authors.affiliation: Division of Industrial Food Research, National Food Institute, Technical University of Denmark, Kgs. Lyngby, Denmark.
authors.forename: Line
authors.initials: L
authors.lastname: Hein-Kristensen
authors.forename: Henrik
authors.initials: H
authors.lastname: Franzyk
authors.forename: Anne
authors.initials: A
authors.lastname: Holch
authors.forename: Lone
authors.initials: L
authors.lastname: Gram
mesh_terms: D000222:Adaptation, Physiological / Q000235:genetics; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D023181:Antimicrobial Cationic Peptides / Q000737:chemistry / Q000494:pharmacology; D001424:Bacterial Infections / Q000382:microbiology; D001425:Bacterial Outer Membrane Proteins / Q000235:genetics; D024881:Drug Resistance, Bacterial / Q000235:genetics*; D004926:Escherichia coli / Q000235:genetics* / Q000254:growth & development; D029968:Escherichia coli Proteins / Q000235:genetics; D019143:Evolution, Molecular; D016695:Glycosyltransferases / Q000235:genetics; D006801:Humans; D054643:INDEL Mutation; D008826:Microbial Sensitivity Tests; D050296:Microbial Viability / Q000187:drug effects* / Q000235:genetics; D015394:Molecular Structure; D009154:Mutation; D010455:Peptides / Q000737:chemistry; D057786:Peptidomimetics / Q000737:chemistry / Q000494:pharmacology*; D020641:Polymorphism, Single Nucleotide; D011112:Polymyxin B / Q000494:pharmacology
chemical_list: D000900:Anti-Bacterial Agents; D023181:Antimicrobial Cationic Peptides; D001425:Bacterial Outer Membrane Proteins; D029968:Escherichia coli Proteins; D010455:Peptides; D057786:Peptidomimetics; D016695:Glycosyltransferases; C021815:murein transglycosylase; D011112:Polymyxin B
references.citation: J Microbiol Methods. 2001 Jan;43(3):183-96
references.pmid: 11118653
references.citation: J Biol Chem. 2011 Feb 18;286(7):5529-39
references.pmid: 21149452
references.citation: Proc Biol Sci. 2006 Jan 22;273(1583):251-6
references.pmid: 16555795
references.citation: mBio. 2013 May 21;4(3):e00021-13
references.pmid: 23695834
references.citation: Biochem Biophys Res Commun. 2005 Sep 9;334(4):1329-35
references.pmid: 16040002
references.citation: Nat Biotechnol. 2006 Dec;24(12):1551-7
references.pmid: 17160061
references.citation: Drug Resist Updat. 2010 Aug-Oct;13(4-5):132-8
references.pmid: 20843473
references.citation: Res Microbiol. 2011 Feb-Mar;162(2):144-50
references.pmid: 21070855
references.citation: J Biol Chem. 2001 Nov 16;276(46):43111-21
references.pmid: 11535603
references.citation: Biochim Biophys Acta. 2008 Nov;1778(11):2487-95
references.pmid: 18675778
references.citation: Nature. 2010 Sep 2;467(7311):82-5
references.pmid: 20811456
references.citation: J Bacteriol. 2006 Feb;188(3):1180-3
references.pmid: 16428424
references.citation: Antimicrob Agents Chemother. 2008 Sep;52(9):3006-12
references.pmid: 18474580
references.citation: Mol Microbiol. 1995 Apr;16(2):271-8
references.pmid: 7565089
references.citation: Science. 2010 Feb 19;327(5968):1010-3
references.pmid: 20167788
references.citation: Antimicrob Agents Chemother. 1984 Apr;25(4):427-32
references.pmid: 6375552
references.citation: J Mol Biol. 2000 Jun 16;299(4):1113-9
references.pmid: 10843862
references.citation: PLoS One. 2009 May 20;4(5):e5629
references.pmid: 19462005
references.citation: Nat Protoc. 2010 Feb;5(2):282-93
references.pmid: 20134428
references.citation: FEMS Microbiol Lett. 1998 Apr 15;161(2):249-54
references.pmid: 9570116
references.citation: Antimicrob Agents Chemother. 2011 Mar;55(3):1177-81
references.pmid: 21149626
references.citation: Planta Med. 2011 Jan;77(2):188-95
references.pmid: 20645243
references.citation: J Biomed Sci. 2010 Jul 24;17:60
references.pmid: 20653976
references.citation: Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):2794-9
references.pmid: 18287037
references.citation: J Exp Med. 1911 Jan 5;13(1):31-42
references.pmid: 19867394
references.citation: Microbiology (Reading). 2003 Jun;149(Pt 6):1367-1375
references.pmid: 12777478
references.citation: J Biol Chem. 2005 Apr 1;280(13):12316-29
references.pmid: 15677462
references.citation: Biochem Biophys Res Commun. 2006 Oct 20;349(2):769-74
references.pmid: 16945333
references.citation: Antimicrob Agents Chemother. 2011 Apr;55(4):1332-7
references.pmid: 21263047
references.citation: Chembiochem. 2010 Jul 5;11(10):1356-60
references.pmid: 20503219
references.citation: Nat Rev Microbiol. 2006 Jul;4(7):529-36
references.pmid: 16778838
references.citation: Nat Biotechnol. 2007 Jun;25(6):657-9
references.pmid: 17529972
references.citation: Antimicrob Agents Chemother. 2010 Aug;54(8):3372-82
references.pmid: 20547815
references.citation: BMC Evol Biol. 2008 Feb 18;8:52
references.pmid: 18282299
references.citation: Trends Microbiol. 1997 Jan;5(1):37-42
references.pmid: 9025234
references.citation: Clin Infect Dis. 2009 Jan 1;48(1):1-12
references.pmid: 19035777
references.citation: Antimicrob Agents Chemother. 2005 Jan;49(1):316-22
references.pmid: 15616311
references.citation: Science. 2009 Aug 28;325(5944):1089-93
references.pmid: 19713519
references.citation: Cell Mol Life Sci. 2011 Jul;68(13):2161-76
references.pmid: 21573784
references.citation: Curr Opin Immunol. 2006 Feb;18(1):24-30
references.pmid: 16337365
references.citation: J Biol Chem. 2008 Nov 21;283(47):32637-43
references.pmid: 18818205
references.citation: Nature. 2005 Oct 13;437(7061):975-80
references.pmid: 16222292
references.citation: Antimicrob Agents Chemother. 2011 Mar;55(3):1211-21
references.pmid: 21149619
references.citation: Res Microbiol. 2013 Nov;164(9):933-40
references.pmid: 23994143
references.citation: J Leukoc Biol. 2005 Apr;77(4):451-9
references.pmid: 15569695
references.citation: Biochim Biophys Acta. 2012 Nov;1818(11):2660-8
references.pmid: 22609348
references.citation: Org Lett. 2007 Apr 12;9(8):1549-52
references.pmid: 17352488
references.citation: BMC Microbiol. 2011 Jun 22;11:144
references.pmid: 21693068
references.citation: Nature. 2002 Jan 24;415(6870):389-95
references.pmid: 11807545
references.citation: Antimicrob Agents Chemother. 1997 Aug;41(8):1738-42
references.pmid: 9257752
references.citation: Int J Antimicrob Agents. 2011 Mar;37(3):187-93
references.pmid: 21295448
references.citation: Antimicrob Agents Chemother. 2009 Aug;53(8):3422-9
references.pmid: 19487442
references.citation: Biochim Biophys Acta. 2011 Jan;1808(1):171-82
references.pmid: 20826126
references.citation: Trends Microbiol. 2008 Jun;16(6):284-90
references.pmid: 18467098
references.citation: Curr Allergy Asthma Rep. 2003 Sep;3(5):402-9
references.pmid: 12906776